Utama › Glioblastoma › Texas › Houston
Kajian klinikal Glioblastoma di Houston, TX
25 kajian untuk Glioblastoma sedang mencari peserta di lokasi dalam dan sekitar Houston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Mengambil pesertaFasa 2/3
- University of Texas - MD Anderson Cancer Center, Houston
GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
Mengambil pesertaFasa 1
- Baylor St. Luke's Medical Center, Houston
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Mengambil pesertaFasa 1/2
- Baylor College of Medicine, Houston
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Mengambil pesertaFasa 1
- M D Anderson Cancer Center, Houston
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Mengambil pesertaFasa 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Anti-GD2 ADC M3554 in Advanced Solid Tumors
Mengambil pesertaFasa 1
- The University of Texas MD Anderson Cancer Center, Houston
Targeted Pediatric High-Grade Glioma Therapy
Mengambil pesertaKajian pemerhatian
- Texas Children's Hospital, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
Study of Olutasidenib and Temozolomide in HGG
Mengambil pesertaFasa 2
- Texas Children's Hospital, Houston
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Mengambil pesertaFasa 3
- MD Anderson Cancer Center, Houston
A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
Mengambil pesertaFasa 1
- Excel Diagnostics & Nuclear Oncology Center, Houston
A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
Mengambil pesertaFasa 1/2
- The University of Texas M. D. Anderson Cancer Center, Houston
- The University of Texas MD Anderson Cancer Center, Houston
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
Mengambil pesertaSukarelawan sihat dialu-alukan
- M D Anderson Cancer Center, Houston
Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
Mengambil pesertaFasa 2
- M D Anderson Cancer Center, Houston
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
Mengambil pesertaFasa 2
- UTHealth Houston, Houston
- Baylor College of Medicine, Houston
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Mengambil pesertaFasa awal 1Sukarelawan sihat dialu-alukan
- Texas Children's Hospital, Houston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Mengambil pesertaFasa 2
- Texas Children's Hospital, Houston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Mengambil pesertaFasa 1/2
- MD Anderson Cancer Center, Houston
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
Mengambil pesertaFasa 1/2
- Houston Methodist Neurological Institute, Houston
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Mengambil pesertaFasa 1/2
- Houston Methodist Neurological Institute, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Houston
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- MD Anderson Cancer Center, Houston
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
Mengambil pesertaFasa 1
- UT MD Anderson Cancer Center, Houston
Kajian Glioblastoma di bandar lain
- New York City, NY30 kajian
- Boston, MA28 kajian
- Los Angeles, CA23 kajian
- Durham, NC20 kajian
- San Francisco, CA17 kajian
- Washington, DC15 kajian
- Chicago, IL15 kajian
- Rochester, MN15 kajian
- Columbus, OH14 kajian
- Miami, FL14 kajian
- Jacksonville, FL13 kajian
- Aurora, CO12 kajian
Kajian lain di Houston
- Kanser Paru-paru Bukan Sel Kecil145 kajian
- Kanser Payudara126 kajian
- Kanser (semua jenis)121 kajian
- Kanser Metastatik104 kajian
- Kanser Kolorektal102 kajian
- Kanser Ovari89 kajian
- Leukemia Mieloid Akut85 kajian
- Kanser Paru-paru78 kajian
- Kanser Prostat76 kajian
- Kanser Endometrium68 kajian
- Kanser Pankreas61 kajian
- Melanoma59 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.